929360071000036103: Medicinal product unit of use reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept\Reference set\Simple type reference set\Medicinal product unit of use reference set

Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module

3288211000168116 MPUU (medicinal product unit of use) reference set en Synonym Active Case sensitive Australian Medicines Terminology module

965507151000036113 Medicinal product unit of use reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module

965507161000036111 Medicinal product unit of use reference set en Synonym Active Case sensitive Australian Medicines Terminology module

4351141000168117 <p>Terminology to describe in a health record an abstract concept representing the properties of one or more equivalent Trade Product Units of Use.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Medicinal product unit of use reference set	Developed by	Australian Digital Health Agency	true	Inferred relationship	Some	615170453
Medicinal product unit of use reference set	Has licence	SNOMED CT-AU licence	true	Inferred relationship	Some	1364130978
Medicinal product unit of use reference set	Is a	Simple type reference set	true	Inferred relationship	Some

Members

brimonidine tartrate 0.2% eye drops

brinzolamide 1% + timolol 0.5% eye drops

brinzolamide 1% eye drops

brivaracetam 10 mg/mL oral liquid

brivaracetam 10 mg tablet

brivaracetam 100 mg tablet

brivaracetam 25 mg tablet

brivaracetam 50 mg/5 mL injection, vial

brivaracetam 50 mg tablet

brivaracetam 75 mg tablet

brolucizumab 6 mg/0.05 mL intraocular injection, syringe

brolucizumab 6 mg/0.05 mL intraocular injection, vial

bromazepam 3 mg tablet

bromazepam 6 mg tablet

bromhexine hydrochloride 12 mg/15 mL + phenylephrine hydrochloride 10 mg/15 mL oral liquid

pholcodine 15 mg/15 mL + bromhexine hydrochloride 12 mg/15 mL oral liquid

bromhexine hydrochloride 12 mg/15 mL + pseudoephedrine hydrochloride 60 mg/15 mL oral liquid

bromhexine hydrochloride 3 mg/5 mL + guaifenesin 100 mg/5 mL oral liquid

bromhexine hydrochloride 4 mg/5 mL + guaifenesin 100 mg/5 mL oral liquid

bromhexine hydrochloride 4 mg/5 mL oral liquid

bromhexine hydrochloride 8 mg + cetylpyridinium chloride 1.33 mg lozenge

bromhexine hydrochloride 8 mg + guaifenesin 200 mg tablet

bromhexine hydrochloride 8 mg/10 mL + guaifenesin 100 mg/10 mL + pseudoephedrine hydrochloride 60 mg/10 mL oral liquid

bromhexine hydrochloride 8 mg/10 mL + guaifenesin 200 mg/10 mL oral liquid

bromhexine hydrochloride 8 mg/5 mL oral liquid

bromhexine hydrochloride 8 mg/5 mL oral liquid, sachet

bromhexine hydrochloride 8 mg soluble tablet

bromhexine hydrochloride 8 mg tablet

bromocriptine 10 mg capsule

bromocriptine 2.5 mg tablet

bromocriptine 5 mg capsule

brompheniramine maleate 2 mg/5 mL + phenylephrine hydrochloride 5 mg/5 mL + dextromethorphan hydrobromide monohydrate 10 mg/5 mL oral liquid

brompheniramine maleate 2 mg/5 mL + phenylephrine hydrochloride 5 mg/5 mL oral liquid

brompheniramine maleate 4 mg + phenylephrine hydrochloride 10 mg tablet

brompheniramine maleate 400 microgram/mL + phenylephrine hydrochloride 1 mg/mL + dextromethorphan hydrobromide monohydrate 2 mg/mL oral liquid

brompheniramine maleate 800 microgram/mL + phenylephrine hydrochloride 1 mg/mL oral liquid

polyvalent Australian snake antivenom injection, vial

brown snake antivenom 1000 units injection, vial

budesonide 1 mg/2 mL inhalation solution, ampoule

budesonide 1 mg orally disintegrating tablet

budesonide 100 microgram / 1 actuation + formoterol fumarate dihydrate 3 microgram / 1 actuation inhalation, actuation (medicinal product unit of use)

budesonide 100 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation inhalation, actuation

budesonide 100 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation, actuation

budesonide 100 microgram/actuation powder for inhalation, actuation

budesonide 160 microgram/actuation + glycopyrronium 7.2 microgram/actuation + formoterol fumarate dihydrate 5 microgram/actuation inhalation, actuation

budesonide 2 mg/application enema

budesonide 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation inhalation, actuation

budesonide 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation, actuation

budesonide 200 microgram/actuation powder for inhalation, actuation

budesonide 3 mg enteric capsule

budesonide 3 mg modified release capsule

budesonide 32 microgram/actuation nasal spray, actuation

budesonide 400 microgram/actuation + formoterol fumarate dihydrate 12 microgram/actuation powder for inhalation, actuation

budesonide 400 microgram/actuation powder for inhalation, actuation

budesonide 50 microgram/actuation + formoterol fumarate dihydrate 3 microgram/actuation inhalation, actuation

budesonide 500 microgram/2 mL inhalation solution, ampoule

budesonide 500 microgram orally disintegrating tablet

budesonide 64 microgram/actuation nasal spray, actuation

budesonide 9 mg modified release tablet

chlorhexidine gluconate 0.1% + lidocaine hydrochloride 1% + bufexamac 5% cream

chlorhexidine gluconate 0.1% + lidocaine hydrochloride monohydrate 1% + bufexamac 5% cream

miconazole nitrate 2% + bufexamac 5% cream

bufexamac 5% cream

bumetanide 1 mg tablet

bupivacaine hydrochloride 0.5% (100 mg/20 mL) injection, vial

bupivacaine hydrochloride 0.5% (20 mg/4 mL) + glucose 320 mg/4 mL intrathecal injection, ampoule

bupivacaine hydrochloride 0.5% (20 mg/4 mL) intrathecal injection, ampoule

bupivacaine hydrochloride 25 mg / 20 mL + fentanyl 100 microgram / 20 mL injection, 20 mL ampoule (medicinal product unit of use)

bupivacaine hydrochloride 0.125% (25 mg/20 mL) + fentanyl 100 microgram/20 mL injection, vial

bupivacaine hydrochloride 0.125% (250 mg/200 mL) + fentanyl 1000 microgram/200 mL injection, bag

bupivacaine hydrochloride 50 mg / 10 mL injection, 10 mL ampoule (medicinal product unit of use)

bupivacaine hydrochloride 0.5% (50 mg/10 mL) injection, vial

bupivacaine hydrochloride 0.25% (50 mg/20 mL) injection, vial

bupivacaine hydrochloride monohydrate 0.5% (100 mg/20 mL) + adrenaline (epinephrine) 1 in 200 000 (100 microgram/20 mL) injection, vial

bupivacaine hydrochloride monohydrate 0.5% (100 mg/20 mL) injection, ampoule

bupivacaine hydrochloride monohydrate 0.5% (11 mg/2.2 mL) + adrenaline (epinephrine) 1 in 200 000 (11 microgram/2.2 mL) injection, cartridge

bupivacaine hydrochloride monohydrate 0.125% (125 mg/100 mL) injection, bag

bupivacaine hydrochloride monohydrate 0.5% (20 mg/4 mL) + glucose monohydrate 320 mg/4 mL intrathecal injection, ampoule

bupivacaine hydrochloride monohydrate 0.25% (25 mg/10 mL) + adrenaline (epinephrine) 1 in 400 000 (25 microgram/10 mL) injection, vial

bupivacaine hydrochloride monohydrate 0.25% (250 mg/100 mL) injection, bag

bupivacaine hydrochloride monohydrate 0.125% (250 mg/200 mL) injection, bag

bupivacaine hydrochloride monohydrate 0.5% (50 mg/10 mL) + adrenaline (epinephrine) 1 in 200 000 (50 microgram/10 mL) injection, vial

bupivacaine hydrochloride monohydrate 0.5% (50 mg/10 mL) injection, ampoule

bupivacaine hydrochloride monohydrate 0.5% (50 mg/10 mL) injection, vial

bupivacaine hydrochloride monohydrate 0.25% (50 mg/20 mL) + adrenaline (epinephrine) 1 in 400 000 (50 microgram/20 mL) injection, vial

bupivacaine hydrochloride monohydrate 0.25% (50 mg/20 mL) injection, ampoule

bupivacaine hydrochloride monohydrate 0.375% (75 mg/20 mL) injection, ampoule

buprenorphine 1.4 mg + naloxone 360 microgram sublingual tablet

buprenorphine 10 microgram/hour patch

buprenorphine 100 mg/0.5 mL modified release injection, syringe

buprenorphine 11.4 mg + naloxone 2.9 mg sublingual tablet

buprenorphine 12 mg + naloxone 3 mg sublingual film

buprenorphine 128 mg/0.36 mL modified release injection, syringe

buprenorphine 15 microgram/hour patch

buprenorphine 16 mg/0.32 mL modified release injection, syringe

buprenorphine 16 mg tablet

buprenorphine 160 mg/0.45 mL modified release injection, syringe

buprenorphine 2 mg + naloxone 500 microgram sublingual film

buprenorphine 2 mg + naloxone 500 microgram sublingual tablet

buprenorphine 2 mg sublingual tablet

buprenorphine 2.9 mg + naloxone 710 microgram sublingual tablet

Start Previous Page 14 of 75 Next End

Reference Sets

Australian dialect reference set

Reference set descriptor